Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.
about
Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecanHuman ABCG2: structure, function, and its role in multidrug resistance.The anticancer agent prodigiosin is not a multidrug resistance protein substrate.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Induction of breast cancer res ...... uction of antitumour activity.
@ast
Induction of breast cancer res ...... uction of antitumour activity.
@en
type
label
Induction of breast cancer res ...... uction of antitumour activity.
@ast
Induction of breast cancer res ...... uction of antitumour activity.
@en
prefLabel
Induction of breast cancer res ...... uction of antitumour activity.
@ast
Induction of breast cancer res ...... uction of antitumour activity.
@en
P2093
P2860
P356
P1476
Induction of breast cancer res ...... uction of antitumour activity.
@en
P2093
A H van Hattum
G Kohlhagen
G L Scheffer
H M M Schlüper
H M Pinedo
I J Hoogsteen
M Maliepaard
R J Scheper
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600508
P407
P577
2002-09-01T00:00:00Z